The US FDA has named the first eight European drug regulatory authorities that it is recognizing under a US/EU mutual recognition agreement reached in March.
It will now be the exception rather than the rule for FDA to inspect pharmaceutical manufacturing facilities in these countries: Austria,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?